Acadia Pharmaceuticals Inc (NASDAQ:ACAD) currently has a daily average trading volume of 1.59M but it saw 1006583 shares traded in last market. With a market cap of 2.37B USD, the company’s current market price of $14.29 came falling about -1.58 while comparing to the previous closing price of $14.52. In past 52 weeks, the stock remained buoying in the range of price level as high as $32.59 and as low as $14.31. In the recent trading on the day, stock has struck highest price mark of $14.15 while lowest mark touched by it was $14.68.
Morgan Stanley downgraded its recommendation for the stock as a “Equal-Weight” from “Overweight” on August 07, 2024 while assigning a price target range of $28-$20. BMO Capital Markets issued its recommendations for the stock as it initiated the price target for the stock is $31.
Over the week, ACAD’s stock price is moving -4.99% down while it is -9.79% when we observe its performance for the past one month. Year-to-date it is -54.36% down and over the past year, the stock is showing a downside performance of -35.86%.
Currently, Acadia Pharmaceuticals Inc’s total number of outstanding shares is 164.65M. Company’s return on investment (ROI) stands at 5.42% and return on equity (ROE) at 6.70%. It has a price to earnings ratio (P/E ratio) of 80.06 while having a 17.37 of forward P/E ratio. Stock’s beta reads 0.37. Stock has a price to book (P/B) ratio of 4.59 while price to sale or P/S ratio amounts to 2.66. Its return on asset (ROA) is 3.93% on average.
